Vascular Disease Overview

Principles

Definition

Vascular disease is the academic and clinical research domain focused on understanding the complex etiology, pathophysiology, diagnosis, treatment, and prevention of disorders affecting the circulatory system's blood vessels, representing a major area of study due to their significant global health impact.

Ontological type

Pathophysiological Mechanisms

Therapeutic Strategies

Etiological Factors

Key developments

Key Figures

Thrombosis-Centric Reconceptualization era

In the Thrombosis-Centric Reconceptualization (1938-1959), Nikolai Anitschkow's histological work reinforced the link between cholesterol-rich plaques and inflammatory-thrombotic activity, reframing atherosclerotic lesions as thrombo-inflammatory processes rather than mere lipid deposits. Paul Dudley White's mid-century clinical approach integrated systemic atherosclerotic burden into risk assessment and early management, tying plaque pathology to embolic risk and thrombotic events. The framework drew on Rudolf Virchow's established thrombosis doctrine, extending it to emphasize plaque erosion, distal occlusion, and arterial calcification as systemic thrombotic phenomena that shape diagnosis. Together these voices helped institute thrombosis-focused reasoning in pathology and clinical practice, marking a shift toward viewing vascular disease through a thrombo-inflammatory lens.

Mechanobiology and Endothelium era

David S. Celermajer [1] emerges as a leading figure in the Mechanobiology and Endothelium era (1960-1997), with institutional ties to University College London [2] and the Chinese University of Hong Kong [3]. His key contributions in this era include establishing non-invasive detection of endothelial dysfunction as a predictor of vascular risk, exemplified by the 1992 paper Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis [4]. By translating endothelial dysfunction into measurable surrogate signals, Celermajer helped fuse endothelial biology with observable disease patterns and population risk assessment within this era, a trajectory underpinned by his ongoing work [1]. The study of endothelial responsiveness and noninvasive vascular assessment in this period laid groundwork for mechanobiology-driven imaging and standardization of risk stratification, as reflected in Celermajer’s influential 1992 work [4].

Precision Risk Stratification era

John J.V. McMurray[1] is a leading figure associated with Harvard University[3] and the University of California, San Francisco[4], contributing to precision risk stratification in vascular disease during this era. His key contribution in this era centers on the European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) [6], which consolidated cross‑society recommendations and demonstrated how standardized risk assessment informs targeted prevention and treatment decisions. Giuseppe Mancia[2] is distinguished by affiliations with Harvard University[3] and Johns Hopkins University[5], illustrating a cross‑institutional lens on vascular risk concepts. Across this era, exemplified by the same European guidelines [6], his work helped translate multidisciplinary consensus into practicality for precision risk stratification and influenced subsequent prevention strategies.